Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scrip 100 Analysis: Sales Up, Profits Down – But Is It Real?

Bellwethers tell you something, but to gauge the health of the pharmaceutical industry, you really need the Scrip 100. For FY 2016, it looks like drug sales are up again and profits are down. But is this what's actually going on?

Scrip 100 Sales & Earnings Growth

Infographic: Scrip 100 Numbers Crunched

This year's Scrip 100 collection is bigger than ever, encompassing 2016 full-year financial data from more than 650 biopharmaceutical companies.

Scrip 100 Sales & Earnings Market Intelligence

The full Scrip 100 data set for 2018 is now available and includes data on R&D spending, total revenues, assets, operating profit and sales for 659 biopharmaceutical companies.

If you are a Scrip subscriber, click here to download the data in Excel format.



Download Scrip 100 league table PDF